Brief: Hyloris And Pleco Therapeutics Partner For Leukaemia And Cancer Treatment

Hyloris Pharmaceuticals SA

10/11/2021 06:18

Nov 10 (Reuters) - Hyloris Pharmaceuticals SA  HYL.BR :
    * BROADENS PIPELINE WITH NOVEL PATENTED COMBINATION PRODUCT
CANDIDATE IN ACUTE MYELOID LEUKAEMIA AND SMALL CELL LUNG CANCER
    * STRATEGIC PARTNERSHIP WITH PLECO THERAPEUTICS FOR A NOVEL
COMBINATION PRODUCT OF CHELATING AGENTS IN AML AND SCLC
    * TO COMMIT €1 MILLION, CONVERTIBLE INTO EQUITY, PLUS
PRE-DEFINED
RESEARCH AND DEVELOPMENT FUNDING THROUGH TO REGULATORY
SUBMISSION

Source text for Eikon:  ID:nGNE29RxSC 
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))